Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin

Biomaterials

Volumn 29, Issue 11, 2008, Pages 1664-1675

  Kono, Kenji ^a   Kojima, Chie ^a   Hayashi, Nobuyuki ^a   Nishisaka, Eiko ^a   Kiura, Katsuyuki ^b   Watarai, Shinobu ^a   Harada, Atsushi ^a  

^a Osaka Prefecture University   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Adriamycin; Chemotherapy; Dendrimer; Drug delivery; Poly(amidoamine); Poly(ethylene glycol)

Indexed keywords

CHEMOTHERAPY; CYTOTOXICITY; DRUG DELIVERY; POLYETHYLENE GLYCOLS;

ADRIAMYCIN; CYTOTOXIC ACTIVITY; GLUTAMIC ACID (GLU); POLY(AMIDOAMINE);

DENDRIMERS;

AMIDE; DENDRIMER; DOXORUBICIN; GLUTAMIC ACID; HYDRAZONE DERIVATIVE; MACROGOL; POLYAMIDOAMINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SYNTHESIS; ENDOSOME; HELA CELL; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; PRIORITY JOURNAL;

CELL LINE, TUMOR; CELL SURVIVAL; DENDRIMERS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; POLYAMINES; POLYETHYLENE GLYCOLS; SENSITIVITY AND SPECIFICITY;

EID: 38749150591     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.12.017     Document Type: Article

References (44)

1. Vicent M., and Duncan R. Polymer conjugates: nanosized medicines for targeting cancer. Trends Biotechnol 24 (2006) 39-47
2. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 6 (2006) 688-701
3. Haag R., and Kratz F. Polymer therapeutics: concepts and applications. Angew Chem Int Ed 45 (2006) 1198-1215
4. Maeda H., Wu J., Sawa T., Matsumura Y., and Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65 (2000) 271-284
5. Iver A.K., Khaled G., Fang J., and Maeda H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 11 (2006) 812-818
6. Lee C.C., MacKay J.A., Frechet J.M., and Szoka F.C. Designing dendrimers for biological applications. Nat Biotechnol 12 (2005) 1517-1526
7. Dvorak M., Kopeckova P., and Kopecek J. High-molecular weight HPMA copolymer-adriamycin conjugates. J Control Release 60 (1999) 321-332
8. Takakura Y., Mahato R.I., Nishikawa M., and Hashida M. Control of pharmacokinetic profiles of drug-macromolecule conjugates. Adv Drug Deliv Rev 19 (1996) 377-399
9. 14Carbon labelled polyvinylpyrrolidone with a relatively low mean molecular weight after intravenous administration. Arzneimittelforschung 27 (1977) 1158-1162
10. Gillies E.R., and Frechet J.M. Dendrimers and dendritic polymers in drug delivery. Drug Discov Today 10 (2005) 35-43
11. Lee C.C., Gillies E.R., Fox M.E., Guillaudeu S.J., Frechet J.M., Dy E.E., et al. A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proc Natl Acad Sci U S A 103 (2006) 16649-16654
12. Gillies E.R., Dy E., Frechet J.M.J., and Szoka F.C. Biological evaluation of polyester dendrimer: poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture. Mol Pharm 2 (2005) 129-138
13. Kojima C., Kono K., Maruyama K., and Takagishi T. Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjug Chem 11 (2000) 910-917
14. Etrych T., Jelinkova M., Rihova B., and Ulbrich K. New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties. J Control Release 73 (2001) 89-102
15. Ulbrich K., and Subr V. Polymeric anticancer drugs with pH-controlled activation. Adv Drug Deliv Rev 56 (2004) 1023-1050
16. Malik N., Evagorou E.G., and Dunkan R. Dendrimer-platinate: a novel approach to cancer chemotherapy. Anticancer Drugs 10 (1999) 767-776
17. Wiwattanapatapee R., Lomlim L., and Saramunee K. Dendrimers conjugates for colonic delivery of 5-aminosalicylic acid. J Control Release 88 (2003) 1-9
18. Kono K., Liu M., and Frechet J.M.J. Design of dendritic macromolecules containing folate or methotrexate residues. Bioconjug Chem 10 (1999) 1115-1121
19. Thomas T.P., Majoros I.J., Kotlyar A., Kukowska-Latallo J.F., Bielinska A., Myc A., et al. Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J Med Chem 48 (2005) 3729-3735
20. Greenwald R.B., Conover C.D., and Choe Y.H. Poly(ethylene glycol) conjugated drugs and prodrugs: a comprehensive review. Crit Rev Ther Drug Carrier Syst 17 (2000) 101-161
21. Ihre H.R., De Jesus O.L.P., Szoka F.C., and Frechet J.M.J. Polyester dendritic systems for drug delivery applications: design, synthesis and characterization. Bioconjug Chem 13 (2002) 443-452
22. Gillies E.R., and Frechet J.M.J. Designing macromolecules for therapeutic applications: polyester dendrimer-poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture. J Am Chem Soc 124 (2002) 14137-14146
23. De Jesus O.L.P., Ihre H.R., Gagne L., Frechet J.M., and Szoka F.C. Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation. Bioconjug Chem 13 (2002) 453-461
24. Kojima C., Toi Y., Harada A., and Kono K. Preparation of poly(ethylene glycol)-attached dendrimers encapsulating photosensitizers for application to photodynamic therapy. Bioconjug Chem 18 (2007) 663-670
25. Haba Y., Harada A., Takagishi T., and Kono K. Synthesis of biocompatible dendrimers with a peripheral network formed by linking of polymerizable groups. Polymer 46 (2005) 1813-1820
26. Tomalia D.A., Baker H., Dewald J., Hall M., Kallos G., Martin S., et al. A new class of polymers: starburst-dendritic macromolecules. Polymer J 17 (1985) 117-132
27. Takahashi T., Kono K., Itoh T., Emi N., and Takagishi T. Synthesis of novel cationic lipids having polyamidoamine dendrons and their transfection activity. Bioconjug Chem 14 (2003) 764-773
28. Kono K., Akiyama H., Takahashi T., Takagishi T., and Harada A. Transfection activity of polyamidoamine dendrimers having hydrophobic amino acid residues in the periphery. Bioconjug Chem 16 (2005) 208-214
29. Kiura K., Ohnoshi T., Tabata M., Shibayama T., and Kimura I. Establishment of adriamycin-resistant subline of human small cell lung cancer showing multifactorial mechanism of resistance. Acta Med Okayama 47 (1993) 191-197
30. Etrych T., Chytil P., Jelínková M., Říhová B., and Ulbrich K. Synthesis of HPMA copolymers containing doxorubicin bound via a hydrazone linkage. Effect of spacer on drug release and in vitro cytotoxicity. Macromol Biosci 2 (2002) 43-52
31. Taatjes D., and Koch T.H. Nuclear targeting and retention of anthracycline antitumor drugs in sensitive and resistant tumor cells. Curr Med Chem 8 (2001) 15-29
32. Dufes C., Uchegbu I.F., and Schatzlein A.G. Dendrimers in gene delivery. Adv Drug Deliv Rev 57 (2005) 2177-2202
33. Allen T.D., Cronshaw J.M., Bagley S., Kiseleva E., and Goldberg M.W. The nuclear pore complex: mediator of translocation between nucleus and cytoplasm. J Cell Sci 113 (2000) 1651-1659
34. Tsuruo T. Mechanisms of multidrug resistance and implications for therapy. Jpn J Cancer Res (Gann) 79 (1988) 285-296
35. Gerlach J.H., Endicott J.A., Juranka P.F., Henderson G., Sarangi F., Deuchars K.L., et al. Homolog between p-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature 324 (1986) 485-489
36. Minko T., Kopeckova P., Pozharov V., and Kopecek J. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. J Control Release 54 (1998) 223-233
37. Minko T., Kopeckova P., and Kopecek J. Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells. Pharm Res 16 (1999) 986-996
38. Ryser H.J.P., and Shen W.C. Conjugation of methotrexate to poly(l-lysine) increases drug transport and overcomes drug resistance in cultured cells. Proc Natl Acad Sci U S A 75 (1978) 3867-3870
39. Gurdag S., Khandare J., Stapels S., Mathely L.H., and Kannan R.M. Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and resistant cell lines. Bioconjug Chem 17 (2006) 275-283
40. Yokoyama M., Okano T., Sakurai Y., Ekimoto H., Shibazaki C., and Kataoka K. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res 51 (1991) 3229-3236
41. Matsumura Y. Preclinical and clinical studies of anticancer drug-incorporated polymeric micelles. J Drug Target 15 (2007) 507-517
42. Nishiyama N., Okazaki S., Cabral H., Miyamoto M., Kato Y., Sugiyama Y., et al. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res 63 (2003) 8977-8983
43. Bae Y., Fukushima S., Harada A., and Kataoka K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew Chem Int Ed 42 (2003) 4640-4643
44. Bae Y., Nishiyama N., Fukushima S., Koyama H., Yasuhiro M., and Kataoka K. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug Chem 16 (2005) 122-130